Company Analysis Aspen Pharmacare Holdings Ltd ADR
1. Summary
Advantages
- Price (9.18 $) is less than fair price (18.73 $)
- Dividends (1.79%) are higher than the sector average (0%).
- Current debt level 26.2% is below 100% and has decreased over 5 years from 464.51%.
- The company's current efficiency (ROE=5.15%) is higher than the sector average (ROE=0%)
Disadvantages
- The stock's return over the last year (-11.07%) is lower than the sector average (41.63%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Aspen Pharmacare Holdings Ltd ADR | Index | ||
|---|---|---|---|
| 7 days | -9.2% | -0.4% | -1.2% |
| 90 days | -3.9% | -0.4% | -6.6% |
| 1 year | -11.1% | 41.6% | 6.9% |
APNHY vs Sector: Aspen Pharmacare Holdings Ltd ADR has significantly underperformed the "" sector by -52.71% over the past year.
APNHY vs Market: Aspen Pharmacare Holdings Ltd ADR has significantly underperformed the market by -17.99% over the past year.
Stable price: APNHY is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: APNHY with weekly volatility of -0.213% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (9.18 $) is lower than the fair price (18.73 $).
Price significantly below the fair price: The current price (9.18 $) is 104% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (24.13) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (24.13) is higher than that of the market as a whole (0).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.25) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (1.25) is higher than that of the market as a whole (0).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.38) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (2.38) is higher than that of the market as a whole (0).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.16) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (13.16) is higher than that of the market as a whole (0).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 264.06% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (264.06%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (5.15%) is higher than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (5.15%) is higher than that of the market as a whole (0%).
5.5. ROA
ROA vs Sector: The company's ROA (3.22%) is higher than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (3.22%) is higher than that of the market as a whole (0%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.79% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.79% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 1.79% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (34.63%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
